Sandeep Athalye is the Chief Executive Officer of Kashiv BioSciences, a biosimilar company focused on developing and commercializing complex injectable.
Dr. Sandeep Athalye is the Chief Executive Officer of Kashiv BioSciences, a biosimilar company focused on developing and commercializing complex injectable therapies. He has held this role since November 2024, leading the company through its acquisition by Amneal Pharmaceuticals in April 2026.
Full founder directory · Investor directory · Company funding database · Fundraising library